BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29280216)

  • 1. Contribution of cervical cytology in the diagnostic work-up of patients with endometrial cancer.
    Amkreutz LCM; Pijnenborg JMA; Joosten DWL; Mertens HJMM; Van Kuijk SMJ; Engelen MJA; Bergmans M; Nolting WE; Kruitwagen RFPM
    Cytopathology; 2018 Feb; 29(1):63-70. PubMed ID: 29280216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cytology in serous and endometrioid endometrial cancer.
    Roelofsen T; Geels YP; Pijnenborg JM; van Ham MA; Zomer SF; van Tilburg JM; Snijders MP; Siebers AG; Bulten J; Massuger LF
    Int J Gynecol Pathol; 2013 Jul; 32(4):390-8. PubMed ID: 23722512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal cervical cytology: a risk factor for endometrial cancer recurrence.
    Brown AK; Gillis S; Deuel C; Angel C; Glantz C; Dubeshter B
    Int J Gynecol Cancer; 2005; 15(3):517-22. PubMed ID: 15882179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
    Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of Glandular Cells at the Preoperative Cervical Cytology and Local Recurrence in Endometrial Cancer.
    Casarin J; Bogani G; Serati M; Pinelli C; Laganà AS; Garzon S; Raspagliesi F; Ghezzi F
    Int J Gynecol Pathol; 2020 Nov; 39(6):522-528. PubMed ID: 31651558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of histological types of endometrial cancer by endometrial cytology.
    Okadome M; Saito T; Nishiyama N; Ariyoshi K; Shimamoto K; Shimada T; Kodama K; Imamura S; Nishiyama K; Taguchi K
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1931-9. PubMed ID: 25056473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of cervico-vaginal cytology in endometrial carcinoma: A systematic review and meta-analysis.
    Frias-Gomez J; Benavente Y; Ponce J; Brunet J; Ibáñez R; Peremiquel-Trillas P; Baixeras N; Zanca A; Piulats JM; Aytés Á; Matias-Guiu X; Bosch FX; de Sanjosé S; Alemany L; Costas L;
    Cancer Cytopathol; 2020 Nov; 128(11):792-802. PubMed ID: 32202704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical implications of positive peritoneal cytology in endometrial cancer].
    Ren YL; Wang HY; Shan BE; Ping B; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype?
    Skaznik-Wikiel ME; Ueda SM; Frasure HE; Rose PG; Fleury A; Grumbine FC; Fader AN
    Acta Cytol; 2011; 55(3):255-60. PubMed ID: 21525737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of FIGO Stage IIIc endometrial cancer patients.
    McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
    Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
    Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
    Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer.
    Sanci M; Güngördük K; Gülseren V; Karadeniz T; Kocaer M; Gungorduk O; Özdemir İA
    Int J Gynecol Pathol; 2018 Jan; 37(1):17-21. PubMed ID: 28319574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic grade and peritoneal cytology as prognostic factors in type 1 endometrial cancer.
    Tanaka K; Kobayashi Y; Sugiyama J; Yamazaki T; Dozono K; Watanabe M; Shibuya H; Nishigaya Y; Momomura M; Matsumoto H; Umezawa S; Takamatsu K; Iwashita M
    Int J Clin Oncol; 2017 Jun; 22(3):533-540. PubMed ID: 28083737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
    Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
    Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter Study.
    Canlorbe G; Bendifallah S; Raimond E; Graesslin O; Hudry D; Coutant C; Touboul C; Bleu G; Collinet P; Darai E; Ballester M
    Ann Surg Oncol; 2015 Aug; 22(8):2714-21. PubMed ID: 25503347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.
    Cuylan ZF; Oz M; Ozkan NT; Comert GK; Sahin H; Turan T; Akbayir O; Kuscu E; Celik H; Dede M; Gungor T; Meydanli MM; Ayhan A
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1140-1149. PubMed ID: 29516573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of surgical staging for obese women with endometrial cancer: a retrospective analysis in a Japanese cohort.
    Todo Y; Okamoto K; Minobe S; Kato H
    Jpn J Clin Oncol; 2014 Oct; 44(10):903-9. PubMed ID: 25098706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.